Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
Autonomix Medical (NASDAQ:AMIX), a medical device company specializing in precision nerve-targeted treatments, has announced its participation in an upcoming virtual investor webinar. The event will be hosted by Ladenburg Thalmann on Thursday, August 21, 2025, at 1:00 PM ET.
The webinar will feature Brad Hauser, President and CEO of Autonomix, in a discussion moderated by Jeffrey S. Cohen, Managing Director and Director of Equity Research at Ladenburg Thalmann. The event will include a Q&A session, with participants able to pre-submit questions via email.
Autonomix Medical (NASDAQ:AMIX), società di dispositivi medici specializzata in trattamenti di precisione mirati ai nervi, ha annunciato la sua partecipazione a un webinar virtuale per investitori. L'evento sarà organizzato da Ladenburg Thalmann giovedì 21 agosto 2025 alle 13:00 ET.
Il webinar vedrà la partecipazione di Brad Hauser, Presidente e CEO di Autonomix, in una conversazione moderata da Jeffrey S. Cohen, Managing Director e Director of Equity Research presso Ladenburg Thalmann. L'evento comprenderà una sessione di domande e risposte; i partecipanti potranno inviare le proprie domande in anticipo via email.
Autonomix Medical (NASDAQ:AMIX), una empresa de dispositivos médicos especializada en tratamientos de precisión dirigidos a los nervios, ha anunciado su participación en un próximo seminario web virtual para inversores. El evento será organizado por Ladenburg Thalmann el jueves 21 de agosto de 2025 a la 1:00 p.m. ET.
El seminario contará con la participación de Brad Hauser, presidente y CEO de Autonomix, en una conversación moderada por Jeffrey S. Cohen, Managing Director y Director de Equity Research en Ladenburg Thalmann. El evento incluirá una sesión de preguntas y respuestas; los participantes podrán enviar preguntas por adelantado por correo electrónico.
Autonomix Medical (NASDAQ:AMIX), 신경 표적 정밀 치료를 전문으로 하는 의료기기 회사가 곧 열리는 가상 투자자 웨비나에 참여한다고 발표했습니다. 본 행사는 Ladenburg Thalmann이 주최하며 2025년 8월 21일 목요일 오후 1시(동부시간)에 진행됩니다.
웨비나에는 Autonomix의 사장 겸 CEO인 Brad Hauser가 참여하며, Ladenburg Thalmann의 Managing Director 겸 주식 리서치 디렉터인 Jeffrey S. Cohen이 토론을 진행합니다. 행사에는 질의응답 시간이 포함되며, 참가자는 이메일로 사전 질문을 제출할 수 있습니다.
Autonomix Medical (NASDAQ:AMIX), une entreprise de dispositifs médicaux spécialisée dans les traitements ciblés et de précision au niveau des nerfs, a annoncé sa participation à un prochain webinaire virtuel destiné aux investisseurs. L'événement sera organisé par Ladenburg Thalmann le jeudi 21 août 2025 à 13h00 (heure de l’Est).
Le webinaire réunira Brad Hauser, président et CEO d'Autonomix, pour une discussion animée par Jeffrey S. Cohen, Managing Director et Director of Equity Research chez Ladenburg Thalmann. L'événement comprendra une séance de questions-réponses ; les participants pourront soumettre leurs questions à l'avance par courriel.
Autonomix Medical (NASDAQ:AMIX), ein Medizintechnikunternehmen, das sich auf präzise nervenzielgerichtete Behandlungen spezialisiert hat, hat seine Teilnahme an einem bevorstehenden virtuellen Investoren-Webinar angekündigt. Die Veranstaltung wird von Ladenburg Thalmann am Donnerstag, 21. August 2025, um 13:00 Uhr ET ausgerichtet.
Am Webinar wird Brad Hauser, Präsident und CEO von Autonomix, teilnehmen; die Diskussion wird moderiert von Jeffrey S. Cohen, Managing Director und Director of Equity Research bei Ladenburg Thalmann. Die Veranstaltung umfasst eine Fragerunde; Teilnehmer können Fragen vorab per E-Mail einreichen.
- None.
- None.
Live video webcast on Thursday, August 21st at 1:00 PM ET
THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced that Brad Hauser, President and Chief Executive Officer will participate in a virtual investor webinar hosted by Ladenburg Thalmann on Thursday, August 21, 2025 and 1:00 PM ET.
The webinar will be moderated by Jeffrey S. Cohen, Managing Director and Director of Equity Research of Ladenburg Thalmann. Following the discussion, there will be a question and answer session. Interested participants may pre-submit questions to events@ladenburg.com ahead of the event.
To register for the webinar, please click here. The webinar will also be accessible on the Events page in the Investors section of the Company’s website (www.autonomix.com)
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.
Investor and Media Contact
JTC Team, LLC
Jenene Thomas
(908) 824-0775
autonomix@jtcir.com
FAQ
When is Autonomix Medical's (AMIX) virtual investor webinar scheduled for?
Who will be presenting at the Autonomix Medical (AMIX) investor webinar?
How can investors participate in the Autonomix Medical (AMIX) webinar?
What is Autonomix Medical's (AMIX) business focus?
